Stegeman C - Search Results

1

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group. Specks U, et al. Among authors: stegeman c. N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277. N Engl J Med. 2013. PMID: 23902481 Free PMC article. Clinical Trial.

2

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

Mulder AH, Stegeman CA, Kallenberg CG. Mulder AH, et al. Among authors: stegeman ca. Clin Exp Immunol. 1995 Aug;101(2):227-32. doi: 10.1111/j.1365-2249.1995.tb08343.x. Clin Exp Immunol. 1995. PMID: 7648707 Free PMC article.

3

Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis.

Stegeman CA, Tervaert JW, Kallenberg CG. Stegeman CA, et al. Ann Med Interne (Paris). 1994;145(8):523-32. Ann Med Interne (Paris). 1994. PMID: 7710178 Review. No abstract available.

4

Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.

Tervaert JW, Stegeman CA, Brouwer E, Mulder AH, Limburg PC, Kallenberg CG. Tervaert JW, et al. Among authors: stegeman ca. Neth J Med. 1994 Dec;45(6):262-72. Neth J Med. 1994. PMID: 7838242 Review.

5

c-ANCA as a marker of Wegener's disease.

Franssen CF, Tervaert JW, Stegeman CA, Kallenberg CG. Franssen CF, et al. Among authors: stegeman ca. Lancet. 1996 Jan 13;347(8994):116; author reply 118. Lancet. 1996. PMID: 8538307 No abstract available.

6

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Stegeman CA, et al. N Engl J Med. 1996 Jul 4;335(1):16-20. doi: 10.1056/NEJM199607043350103. N Engl J Med. 1996. PMID: 8637536 Free article. Clinical Trial.

7

Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides.

Tervaert JW, Stegeman CA, Kallenberg CG. Tervaert JW, et al. Among authors: stegeman ca. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):241-5. Sarcoidosis Vasc Diffuse Lung Dis. 1996. PMID: 8946592 Review. No abstract available.

8

Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis.

Kallenberg CG, Stegeman CA, Tervaert JW. Kallenberg CG, et al. Among authors: stegeman ca. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):253-5. Sarcoidosis Vasc Diffuse Lung Dis. 1996. PMID: 8946595 Review. No abstract available.

9

Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?

Stegeman CA, Tervaert JW, Kallenberg CG. Stegeman CA, et al. Nephrol Dial Transplant. 1997 Apr;12(4):652-5. doi: 10.1093/ndt/12.4.652. Nephrol Dial Transplant. 1997. PMID: 9140987 Review. No abstract available.

10

Silicon exposure and vasculitis.

Tervaert JW, Stegeman CA, Kallenberg CG. Tervaert JW, et al. Among authors: stegeman ca. Curr Opin Rheumatol. 1998 Jan;10(1):12-7. doi: 10.1097/00002281-199801000-00003. Curr Opin Rheumatol. 1998. PMID: 9448985 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page